Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.
-
- Hatano Takashi
- Department of Urology, Jikei University School of Medicine
-
- Igarashi Hiroshi
- Department of Urology, Jikei University School of Medicine
-
- Furuta Nozomu
- Department of Urology, Jikei University School of Medicine
-
- Kiyota Hiroshi
- Department of Urology, Jikei University School of Medicine
-
- Kishimoto Koichi
- Department of Urology, Jikei University School of Medicine
-
- Oishi Yukihiko
- Department of Urology, Jikei University School of Medicine
Bibliographic Information
- Other Title
-
- 初回化学療法としてCVD療法が奏効した悪性褐色細胞腫の1例
Search this article
Description
We conducted combination therapy with cyclophosphamide, vincristine, and dacarbazine (CVD) for recurrent malignant pheochromocytoma. A 41-year-old woman with ectopic malignant pheochromocytoma had metastases to the liver and left cervical lymph node 7 months after removal of theprimary lesion. At the beginning of October 1999, she was treated with fhe CVD regimen. After 3 courses of chemotherapy, metastases disappeared and urinary catecholamine decreased to normal levels. Only serum noradrenalin was not normalized by the end of treatment. Nine months later, computed tomography (CT) scans of the cervix andabdomen showed recurrent tumors. The woman was treated with the CVD regimen again, but tumor size and biochemical tumor markers remained unchanged. The CVD regimen was thus effective as a primary treatment for malignant pheochiromocytoma with metastases.
Journal
-
- Japanese Journal of Chemotherapy
-
Japanese Journal of Chemotherapy 49 (8), 496-499, 2001
Japanese Society of Chemotherapy
- Tweet
Details 詳細情報について
-
- CRID
- 1390001206285175808
-
- NII Article ID
- 130004298075
- 10006990283
-
- NII Book ID
- AN10472127
-
- ISSN
- 18845886
- 13407007
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed